用于减轻肾缺血再灌注损伤的介孔锌多酚纳米酶

Zepeng Li, Jingyue Qin, Youyou Feng, Chenguang Ding, Yingcong Guo, Zhenting Zhao, Shirui Sun, Jin Zheng, Mingzhen Zhang, Jing Zhang, Yilei Zhang, Jing Wei, Wujun Xue
{"title":"用于减轻肾缺血再灌注损伤的介孔锌多酚纳米酶","authors":"Zepeng Li, Jingyue Qin, Youyou Feng, Chenguang Ding, Yingcong Guo, Zhenting Zhao, Shirui Sun, Jin Zheng, Mingzhen Zhang, Jing Zhang, Yilei Zhang, Jing Wei, Wujun Xue","doi":"10.1080/17435889.2024.2382667","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To target the reactive oxygen species (ROS) accumulation and renal tubular epithelial cell (rTEC) death in renal ischemia-reperfusion injury (IRI), we constructed a nanoparticle that offers ROS scavenging and rTEC-death inhibition: mesoporous zinc-tannic acid nanozyme (ZnTA). <b>Materials & methods:</b> After successfully constructing ZnTA, we proceeded to examine its effect on ROS accumulation, cellular ferroptosis and apoptosis, as well as injury severity. <b>Results:</b> Malondialdehyde, Fe<sup>2+</sup> amounts and 4-HNE staining demonstrated that ZnTA effectively attenuated rTEC ferroptosis. TUNEL staining confirmed that Zn<sup>2+</sup> carried by ZnTA could effectively inhibit caspase 3 and caspase 9, mitigating apoptosis. Finally, it reduced renal IRI through the synergistic effect of ROS scavenging and cell-death inhibition. <b>Conclusion:</b> This study is expected to provide a paradigm for a combined therapeutic strategy for renal IRI.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mesoporous zinc-polyphenol nanozyme for attenuating renal ischemia-reperfusion injury.\",\"authors\":\"Zepeng Li, Jingyue Qin, Youyou Feng, Chenguang Ding, Yingcong Guo, Zhenting Zhao, Shirui Sun, Jin Zheng, Mingzhen Zhang, Jing Zhang, Yilei Zhang, Jing Wei, Wujun Xue\",\"doi\":\"10.1080/17435889.2024.2382667\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Aim:</b> To target the reactive oxygen species (ROS) accumulation and renal tubular epithelial cell (rTEC) death in renal ischemia-reperfusion injury (IRI), we constructed a nanoparticle that offers ROS scavenging and rTEC-death inhibition: mesoporous zinc-tannic acid nanozyme (ZnTA). <b>Materials & methods:</b> After successfully constructing ZnTA, we proceeded to examine its effect on ROS accumulation, cellular ferroptosis and apoptosis, as well as injury severity. <b>Results:</b> Malondialdehyde, Fe<sup>2+</sup> amounts and 4-HNE staining demonstrated that ZnTA effectively attenuated rTEC ferroptosis. TUNEL staining confirmed that Zn<sup>2+</sup> carried by ZnTA could effectively inhibit caspase 3 and caspase 9, mitigating apoptosis. Finally, it reduced renal IRI through the synergistic effect of ROS scavenging and cell-death inhibition. <b>Conclusion:</b> This study is expected to provide a paradigm for a combined therapeutic strategy for renal IRI.</p>\",\"PeriodicalId\":74240,\"journal\":{\"name\":\"Nanomedicine (London, England)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanomedicine (London, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17435889.2024.2382667\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2024.2382667","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:针对肾缺血再灌注损伤(IRI)中的活性氧(ROS)积累和肾小管上皮细胞(rTEC)死亡,我们构建了一种可清除 ROS 并抑制 rTEC 死亡的纳米粒子:介孔锌-单宁酸纳米酶(ZnTA)。材料与方法:成功构建 ZnTA 后,我们开始研究它对 ROS 积累、细胞铁凋亡和凋亡以及损伤严重程度的影响。结果丙二醛、Fe2+ 量和 4-HNE 染色表明,ZnTA 能有效减轻 rTEC 的铁卟啉沉积。TUNEL 染色证实,ZnTA 所携带的 Zn2+ 能有效抑制 caspase 3 和 caspase 9,从而减轻细胞凋亡。最后,它通过清除 ROS 和抑制细胞死亡的协同作用降低了肾脏 IRI。结论这项研究有望为肾脏 IRI 的综合治疗策略提供范例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Mesoporous zinc-polyphenol nanozyme for attenuating renal ischemia-reperfusion injury.

Aim: To target the reactive oxygen species (ROS) accumulation and renal tubular epithelial cell (rTEC) death in renal ischemia-reperfusion injury (IRI), we constructed a nanoparticle that offers ROS scavenging and rTEC-death inhibition: mesoporous zinc-tannic acid nanozyme (ZnTA). Materials & methods: After successfully constructing ZnTA, we proceeded to examine its effect on ROS accumulation, cellular ferroptosis and apoptosis, as well as injury severity. Results: Malondialdehyde, Fe2+ amounts and 4-HNE staining demonstrated that ZnTA effectively attenuated rTEC ferroptosis. TUNEL staining confirmed that Zn2+ carried by ZnTA could effectively inhibit caspase 3 and caspase 9, mitigating apoptosis. Finally, it reduced renal IRI through the synergistic effect of ROS scavenging and cell-death inhibition. Conclusion: This study is expected to provide a paradigm for a combined therapeutic strategy for renal IRI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Amitriptyline nanoparticle repositioning prolongs the anti-allodynic effect of enhanced microglia targeting. Membrane-camouflaged biomimetic nanoplatform with arsenic complex for synergistic reinforcement of liver cancer therapy. Nanoparticle-delivered quercetin exhibits enhanced efficacy in eliminating iron-overloaded senescent chondrocytes. A drug delivery system of HIF-1α siRNA nanoparticles loaded by mesenchymal stem cells on choroidal neovascularization. LC-MS/MS method for simultaneous Doxorubicin and Baicalein estimation: formulation and pharmacokinetic applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1